Phathom Pharmaceuticals, Inc. (PHAT)
13.19
+0.58
(+4.60%)
USD |
NASDAQ |
Apr 17, 16:00
13.18
-0.01
(-0.08%)
After-Hours: 20:00
Phathom Pharmaceuticals Shareholders Equity (Quarterly) : -438.17M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Replimune Group, Inc. | 210.54M |
| ANI Pharmaceuticals, Inc. | 540.72M |
| MannKind Corp. | -51.02M |
| Ocugen, Inc. | -12.17M |
| Ligand Pharmaceuticals, Inc. | 1.017B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 259.80M |
| Total Liabilities (Quarterly) | 697.97M |
| Debt to Equity Ratio | -1.345 |
| Current Ratio | 1.734 |
| Net Debt Paydown Yield | -1.18% |